insights_auto
Why is PTX down 3.45%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.056
arrow_downward
-3.45%(-0.0020) 1D
Nov 16, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
61.92M
Avg. vol.
449.05K
Volume
303.96K
52-wk high
A$0.12
52-wk low
A$0.05
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
61.92M
Avg. vol.
449.05K
Volume
303.96K
52-wk high
A$0.12
52-wk low
A$0.05
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Benzinga
·
56 minutes ago
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
Benzinga
·
7 minutes ago
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
2 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
1 hour ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteptxtherapeutics.com